David Meeker

Insider Reports History

Entity
Individual
Location
C/O Penwest Pharmaceuticals Co, 39 Old Ridgebury Road Suite 11, Danbury, CT
Signature
/s/ Stephen Vander Stoep, Attorney-in-Fact for David Meeker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Meeker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RHYTHM PHARMACEUTICALS, INC. President and CEO, Director Common Stock 201K $11.5M $57.22 Feb 19, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. President and CEO, Director Restricted Stock Units 63.8K $3.65M $57.22 Feb 16, 2025 Direct
Trevi Therapeutics, Inc. Director Common Stock 352K $1.03M $2.93 Aug 27, 2024 Direct
RHYTHM PHARMACEUTICALS, INC. President and CEO, Director Stock Option (Right to Buy) 259K Feb 16, 2024 Direct
RHYTHM PHARMACEUTICALS, INC. President and CEO, Director Stock Options (Right to Buy) 200K Feb 14, 2025 Direct
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 30K Jun 13, 2024 Direct
Trevi Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 27, 2024 Direct

Insider Reports Filed by David Meeker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 14, 2025 5 -$566K 4 Feb 19, 2025 President and CEO, Director
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 1, 2025 3 -$254K 4 Feb 4, 2025 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Aug 27, 2024 3 -$6.84K 4 Aug 29, 2024 Director
TRVI Trevi Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Mar 19, 2024 1 -$1.78M 4 Mar 19, 2024 President and CEO, Director
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 16, 2024 3 $0 4 Feb 21, 2024 President and CEO, Director
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 1, 2024 3 -$197K 4 Feb 5, 2024 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 1, 2023 2 $0 4 Feb 3, 2023 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 23, 2022 1 $0 4/A Jul 1, 2022 Director
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 9, 2022 1 $0 4 Feb 11, 2022 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director